ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2335

Osteoporotic Fracture Trends in a Population of US Managed Care Enrollees: 2007-2017

E. Michael Lewiecki1, Benjamin Chastek2, Kevin Sundquist2, Setareh A. Williams3, Deane Leader Jr.3, Richard Weiss3, Yamei Wang3, Lorraine A Fitzpatrick3 and Jeffrey R. Curtis4, 1New Mexico Clinical Research & Osteoporosis Center, Albuquerque, NM, 2Optum, Eden Prairie, MN, 3Radius Health, Inc., Waltham, MA, 4University of Alabama at Birmingham, Birmingham, AL

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Bone, fractures, osteoporosis and payers

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Osteoporosis and Metabolic Bone Disease – Basic and Clinical Science Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Osteoporosis-related fractures (fractures) are a leading cause of morbidity and disability in the US. Epidemiological data on the occurrence of fractures are limited and required to inform healthcare providers, payers, and policymakers on the scope of this disease. The objective of this analysis was to assess the incidence of fractures in a population of managed care enrollees over the past decade.

Methods: The study included commercial and Medicare Advantage health plan members who had evidence of a qualifying fracture between Jan 2007 and May 2017 (identification period). Fractures were considered qualifying if they were either identified during an inpatient stay or were identified in an outpatient setting based on primary or secondary ICD-9 or ICD-10 accompanied by a repair procedure code. Patients ≥50 years of age with evidence of a qualifying fracture were included. The denominator population comprised members who were ≥50 years of age during the year of interest. The number of days the member was enrolled in the health plan during the year was calculated and was used to determine the total person-years (py) of enrollment for the denominator. Incidence rate is reported as number of events per 1000 py of enrollment during each year from 2007-May 2017. Rates are presented stratified by age category (50-64 vs ≥65) and gender (male vs. female). Patients were categorized by 5-year age increments and gender, and an overall age-gender adjusted rate was calculated.

Results: Of 1,841,263 members with fractures in the identification period, 513,176 met the eligibility criteria. The overall age-gender adjusted rate fell from 14.67/1000 py in 2007 to 11.80/1000 py in 2012, and then did not decrease from 2013- May 2017. Among females ≥65 years old the incidence of fractures declined from 27.49/1000 py in 2007 to 22.08/1000 py in 2013, and then did not decrease from 2014- May 2017. Similarly, among males ≥65 years old incidence decreased from 12.00/1000 py in 2007 to 10.72/1000 py in 2013 and then did not decrease from 2014- May 2017. For males and females ages 50-64 the rates were consistent across years, approximately 4.2 and 7.2 fractures per 1000 py, respectively.

Conclusion: The current study findings suggest fracture incidence has remained the same and potentially rising since 2014. The current study results may reflect insufficient diagnosis and treatment of osteoporosis and support the call to action to increase diagnosis and treatment of osteoporosis especially in older adults.


Disclosure: E. M. Lewiecki, Merck & Co., 5,AbbVie Inc., 5,AgNovos Healthcare, 5,Alexion Pharmaceuticals, 5,Amgen Inc., 5,Eli Lilly and Co., 5,Radius Health, Inc., 5,Shire Pharmaceuticals, 5,TheraNova, 5,Merck & Co., 2,Amgen Inc., 2,Eli Lilly and Co., 2; B. Chastek, Radius Health, Inc., 5,Radius Health, Inc., 5; K. Sundquist, Radius Health, Inc., 5,Radius Health, Inc., 5; S. A. Williams, Radius Health, Inc., 1, 3; D. Leader Jr., Radius Health, Inc., 3; R. Weiss, Radius Health, Inc., 3; Y. Wang, Radius Health, Inc, 3; L. A. Fitzpatrick, Radius Health, Inc., 3; J. R. Curtis, Radius Health, Inc., 5.

To cite this abstract in AMA style:

Lewiecki EM, Chastek B, Sundquist K, Williams SA, Leader D Jr., Weiss R, Wang Y, Fitzpatrick LA, Curtis JR. Osteoporotic Fracture Trends in a Population of US Managed Care Enrollees: 2007-2017 [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/osteoporotic-fracture-trends-in-a-population-of-us-managed-care-enrollees-2007-2017/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/osteoporotic-fracture-trends-in-a-population-of-us-managed-care-enrollees-2007-2017/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology